Photo taken from Vivek Subbiah/LinkedIn
Aug 31, 2023, 19:03
Vivek Subbiah: The evidence for different approaches to colorectal cancer screening is reviewed and a framework for evaluation of screening programs going forward is proposed.
Vivek Subbiah, the Chief of Early-Phase Drug Development at Sarah Cannon Research Institute, recently tweeted:
“Screening for colorectal cancer is widespread and successful, but screening programs across the globe differ in their recommendations. In this review article, the evidence for different approaches to colorectal cancer screening is reviewed and a framework for evaluation of screening programs going forward is proposed.”
For the article click here.
Source: Vivek Subbiah/LinkedIn
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Dec 22, 2024, 11:49
Dec 22, 2024, 11:42
Dec 22, 2024, 10:51
Dec 22, 2024, 10:44